Pacira BioSciences, Inc. (PCRX) has a market capitalization of $1.02B and trades at $23.75. The 52-week range is 18.8-27.64.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 148.4, Earnings Per Share (EPS) of $0.16, annual revenue of $726.41M.
The stock has a beta of 0.20, operates in the Healthcare sector.